Audentes Therapeutics (BOLD) Tops Q3 EPS by 1c
Tweet
Share
E-mail
Get Alerts BOLD Hot Sheet
Join SI Premium – FREE
Audentes Therapeutics (NASDAQ: BOLD) reported Q3 EPS of ($0.88), $0.01 better than the analyst estimate of ($0.89).
For earnings history and earnings-related data on Audentes Therapeutics (BOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Albertsons (ACI) Misses Q1 EPS by 12c; offers guidance
- Acme United (ACU) Tops Q2 EPS by 41c
- Rollins shares plunge premarket after Q2 miss triggers downgrades
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
